Target intelligence / Profile preview

phosphoribosylaminoimidazole carboxylase, phosphoribosylaminoimidazole succinocarboxamide synthetase pseudogene 3 (PAICSP3)

Target
PAICSP3
Molecular classification
Pseudogene
01

Overview

PAICSP3 is formally described as a pseudogene derived from the fusion or colocation of two functional domains: phosphoribosylaminoimidazole carboxylase and phosphoribosylaminoimidazole succinocarboxamide synthetase. These domains, when encoded in active genes, are essential enzymes in de novo purine biosynthesis, catalyzing sequential steps in the formation of inosine monophosphate (IMP). As a pseudogene, PAICSP3 does not produce functional protein and lacks enzymatic activity, thus it is not a valid therapeutic target, receptor, enzyme, or transporter. Its inclusion in target lists likely reflects a database artifact or misannotation, and the nomenclature combining two enzyme domains with "pseudogene" designator and a number suffix (3) is uncommon, making the entry potentially problematic for structured biochemical and pharmacological analysis. The underlying functional enzymes belong to the Enzyme class, particularly ligases/carboxylases, acting in purine biosynthesis. PAICSP3 itself is not implicated in biological function or disease, and does not interact with drugs. If structured information is required, this entry should be flagged as incorrect or non-target.

02

Mechanism of action

None applicable to the pseudogene.

03

Biological functions

None (for the pseudogene itself)
04

Disease associations

None documented (for the pseudogene)

Beyond the preview

Go deeper on phosphoribosylaminoimidazole carboxylase, phosphoribosylaminoimidazole succinocarboxamide synthetase pseudogene 3 (PAICSP3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on phosphoribosylaminoimidazole carboxylase, phosphoribosylaminoimidazole succinocarboxamide synthetase pseudogene 3 (PAICSP3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call